MADRIGAL PHARMACEUTICALS, INC.
Total Trades
91
Buys
4
Sells
53
Largest Trade
N/A
Insiders
14
Institutional Funds
313
Inst. Value
$1M+
Activist Filings
38
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dier Mardi | EVP and CFO | SELL | $500K+ | 1K | $427.21 | Mar 2, 2026 |
| Huntsman Carole | Chief Commercial O… | SELL | $100K–$500K | 910 | $493.78 | Jan 26, 2026 |
| Sibold William John | President and CEO | SELL | $500K+ | 2K | $492.42 | Jan 26, 2026 |
| Taub Rebecca | Director | SELL | $100K–$500K | 647 | $492.42 | Jan 26, 2026 |
| Kelley Shannon T | General Counsel | SELL | $100K–$500K | 692 | $497.36 | Jan 20, 2026 |
| Taub Rebecca | Director | SELL | $1M+ | 2K | $490.77 | Jan 20, 2026 |
| FRIEDMAN PAUL A | Director | SELL | $100K–$500K | 280 | $551.24 | Jan 13, 2026 |
| FRIEDMAN PAUL A | Director | EXERCISE | $1K–$15K | 280 | $15.80 | Jan 13, 2026 |
| FRIEDMAN PAUL A | Director | SELL | $1M+ | 25K | $522.39 | Jan 13, 2026 |
| FRIEDMAN PAUL A | Director | EXERCISE | $100K–$500K | 25K | $15.80 | Jan 13, 2026 |
| Taub Rebecca | Director | SELL | $100K–$500K | 240 | $550.33 | Jan 13, 2026 |
| Taub Rebecca | Director | EXERCISE | $1K–$15K | 240 | $15.80 | Jan 13, 2026 |
| Taub Rebecca | Director | SELL | $1M+ | 18K | $522.40 | Jan 13, 2026 |
| Taub Rebecca | Director | EXERCISE | $100K–$500K | 18K | $15.80 | Jan 13, 2026 |
| FRIEDMAN PAUL A | Director | SELL | $1M+ | 25K | $552.18 | Dec 12, 2025 |
| FRIEDMAN PAUL A | Director | EXERCISE | $100K–$500K | 25K | $15.80 | Dec 12, 2025 |
| Taub Rebecca | Director | EXERCISE | $100K–$500K | 19K | $15.80 | Dec 12, 2025 |
| Taub Rebecca | Director | SELL | $1M+ | 19K | $552.15 | Dec 12, 2025 |
| Sibold William John | President and CEO | EXERCISE | N/A | 50K | — | Dec 4, 2025 |
| Sibold William John | President and CEO | SELL | $1M+ | 2K | $575.34 | Dec 4, 2025 |
| Dier Mardi | EVP and CFO | EXERCISE | $1M+ | 4K | $251.63 | Dec 3, 2025 |
| Dier Mardi | EVP and CFO | SELL | $1M+ | 4K | $578.34 | Dec 3, 2025 |
| Huntsman Carole | Chief Commercial O… | SELL | $1M+ | 2K | $553.11 | Nov 21, 2025 |
| Levy Richard S | Director | EXERCISE | $100K–$500K | 9K | $13.78 | Nov 14, 2025 |
| Levy Richard S | Director | SELL | $1M+ | 9K | $520.96 | Nov 14, 2025 |
| BATE KENNETH | Director | SELL | $1M+ | 17K | $484.30 | Nov 7, 2025 |
| BATE KENNETH | Director | EXERCISE | $1M+ | 17K | $205.07 | Nov 7, 2025 |
| Sibold William John | President and CEO | SELL | $1M+ | 7K | $445.63 | Sep 10, 2025 |
| Taub Rebecca | Director | EXERCISE | $1K–$15K | 1K | $9.45 | Jul 22, 2025 |
| Taub Rebecca | Director | SELL | $100K–$500K | 1K | $350.00 | Jul 22, 2025 |
| FRIEDMAN PAUL A | Director | SELL | $100K–$500K | 1K | $350.03 | Jul 22, 2025 |
| FRIEDMAN PAUL A | Director | EXERCISE | $1K–$15K | 1K | $9.45 | Jul 22, 2025 |
| FRIEDMAN PAUL A | Director | SELL | $1M+ | 29K | $353.19 | Jul 18, 2025 |
| FRIEDMAN PAUL A | Director | EXERCISE | $100K–$500K | 29K | $9.45 | Jul 18, 2025 |
| Taub Rebecca | Director | EXERCISE | $100K–$500K | 29K | $9.45 | Jul 18, 2025 |
| Taub Rebecca | Director | SELL | $1M+ | 29K | $353.19 | Jul 18, 2025 |
| CRAVES FRED B | Director | SELL | $1M+ | 15K | $328.54 | Mar 14, 2025 |
| CRAVES FRED B | Director | EXERCISE | $1M+ | 15K | $82.90 | Mar 14, 2025 |
| Dier Mardi | SVP and CFO | SELL | $50K–$100K | 258 | $323.04 | Mar 12, 2025 |
| Daly James M | Director | SELL | $1M+ | 15K | $347.45 | Feb 28, 2025 |
| Daly James M | Director | EXERCISE | $1M+ | 15K | $82.90 | Feb 28, 2025 |
| BATE KENNETH | Director | EXERCISE | $1M+ | 20K | $66.26 | Feb 28, 2025 |
| BATE KENNETH | Director | SELL | $1M+ | 20K | $356.44 | Feb 28, 2025 |
| Huntsman Carole | Chief Commercial O… | SELL | $100K–$500K | 347 | $335.24 | Jan 27, 2025 |
| Sibold William John | President and CEO | SELL | $500K+ | 2K | $335.24 | Jan 27, 2025 |
| Taub Rebecca | Pres., R&D, and CMO | SELL | $100K–$500K | 648 | $335.24 | Jan 27, 2025 |
| Waltermire Robert E. | Senior VP | SELL | $15K–$50K | 103 | $335.24 | Jan 27, 2025 |
| Kelley Shannon T | General Counsel | SELL | $50K–$100K | 277 | $273.41 | Jan 18, 2025 |
| Waltermire Robert E. | Senior VP | SELL | $100K–$500K | 442 | $273.41 | Jan 18, 2025 |
| Taub Rebecca | Pres., R&D, and CMO | SELL | $100K–$500K | 2K | $273.41 | Jan 18, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 313 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PAULSON & CO. INC. | 1.7M | $1M+ | SH |
| STATE STREET CORP | 583K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 392K | $1M+ | SH |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 354K | $1M+ | SH |
| LORD, ABBETT & CO. LLC | 241K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 219K | $1M+ | SH |
| NORGES BANK | 196K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 185K | $1M+ | SH |
| Pictet Asset Management Holding SA | 182K | $1M+ | SH |
| Erste Asset Management GmbH | 141K | $1M+ | SH |
| Point72 Asset Management, L.P. | 126K | $1M+ | SH |
| MPM BioImpact LLC | 97K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 84K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 83K | $1M+ | SH |
| NEW YORK STATE COMMON RETIREMENT FUND | 76K | $1M+ | SH |
| Squarepoint Ops LLC | 75K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 74K | $1M+ | SH |
| UBS Group AG | 68K | $1M+ | SH |
| First Light Asset Management, LLC | 67K | $1M+ | SH |
| Candriam S.C.A. | 64K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
7.5%
1.7M shares
SC 13G/A · Feb 17, 2026
7.0%
1.6M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13G/A · Nov 14, 2025
8.3%
1.8M shares
SC 13G/A · Aug 14, 2025
9.9%
2.2M shares
SC 13G/A · May 14, 2025
10.0%
2.2M shares
SC 13G/A · Feb 14, 2025
10.1%
2.2M shares
SC 13G/A · Nov 14, 2024
9.4%
2.0M shares
SC 13G · Nov 14, 2024
9.2%
2.0M shares
SC 13D/A · Mar 25, 2024
10.0%
2.1M shares
SC 13G/A · Feb 14, 2024
5.6%
1.1M shares
SC 13G/A · Feb 14, 2024
0.3%
50K shares
SC 13G/A · Feb 14, 2024
9.9%
2.3M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 13, 2024
14.7%
2.9M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.0%
1.6M shares
SC 13G/A · Jan 29, 2024
6.1%
1.2M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 22, 2024
3.5%
0 shares
SC 13D/A · Dec 13, 2023
2.9%
568K shares
SC 13D/A · Nov 21, 2023
10.0%
2.0M shares
SC 13G · Nov 13, 2023
5.1%
1.0M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Oct 10, 2023
15.4%
3.0M shares
SC 13D/A · Oct 5, 2023
10.0%
2.0M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Sep 8, 2023
10.3%
1.9M shares
SC 13D/A · Aug 8, 2023
8.4%
1.5M shares
SC 13D · Jun 16, 2023
8.4%
1.5M shares
SC 13G/A · Feb 14, 2023
9.0%
1.5M shares
SC 13G/A · Feb 14, 2023
1.2%
208K shares
SC 13G/A · Feb 14, 2023
9.7%
1.7M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 2, 2023
7.4%
0 shares
SC 13G/A · Feb 1, 2023
5.8%
987K shares
SC 13G · May 19, 2022
5.4%
918K shares
SC 13G · Feb 14, 2022
6.6%
1.1M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
SC 13G/A · Feb 11, 2022
8.3%
1.4M shares